Effect of treatment with benralizumab or mepolizumab on the serum proteome in eosinophilic granulomatosis with polyangiitis - Vienna 2024

Insights into the latest cellular and molecular perspectives in COPD and asthma

Chair(s): Laurent Boyer, Arnaud Mailleux

Session type: Poster session

Effect of treatment with benralizumab or mepolizumab on the serum proteome in eosinophilic granulomatosis with polyangiitis

Eva Rodriguez-Suarez

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Nasal periostin expression is higher in asthma patients with versus without persistent airflow limitation

Tessa Kole

Abstract

Exploring the Therapeutic Potential of Isorhamnetin in the Treatment of Chronic Obstructive Pulmonary Disease via the Ferroptosis Pathway: A Network Pharmacology and Experimental Study

Zhiwei Lin

Abstract

Inflammatory lipid mediators in Chronic Obstructive Pulmonary Disease: Association with the disease severity

Warda Jelassi

Poster

Abstract

Genetic pathway score for IL-4/IL-13 signaling is associated with diseases that respond to Dupilumab

Manuel Ferreira

Poster

Abstract

Predictive and therapeutic value of lipoprotein-associated phospholipaseA2 in sarcopenia in chronic obstructive pulmonary disease

Gang Hou

Poster

Abstract

Mitochondrial beta-oxidation is altered in response to prednisolone intervention in mepolizumab treated severe eosinophilic asthma

Craig Wheelock

Poster

Abstract

Asthma improvement and normalization of host defence: a longitudinal proteomics cluster analysis

Rita Amaral

Poster

Abstract

FNDC5/irisin regulates mitochondrial function in airway subepithelial fibrosis of severe asthma

Wun-hao Cheng

Poster

Abstract

RNA alternative splicing events as biomarkers for asthma-chronic obstructive pulmonary disease overlap

Jung Hur

Poster

Abstract

Effect of treatment with benralizumab or mepolizumab on the serum proteome in eosinophilic granulomatosis with polyangiitis

Eva Rodriguez-suarez

Poster

Abstract

Connecting the salivary microbiome and blood epigenome with a machine learning interaction approach in children with moderate-to-severe asthma

Jelle M. Blankestijn

Poster

Abstract

Nasal epithelial gene expression data improves the prediction of asthma exacerbations

Rui Mar?alo

Poster

Abstract

ADAM29 elevation in patients with COPD and its association with lung function

Shinhee Park

Poster

Abstract

Nasal gene expression in T2-low asthma

Tatiana Karp

Poster

Abstract

The NOVELTY nasal transcriptome identifies mechanisms in asthma and COPD exacerbators

Rosa Faner Canet

Poster

Abstract

Serum RNASE3 and TREM2 biomarker set predicts clinical response to benralizumab in nasal polyps

Zala Jevnikar Rojnik

Poster

Abstract

Transcriptomic determinants of response to biological therapy (BT) in severe uncontrolled asthma (SUA)

Bartomeu Mestre Ca?as

Poster

Abstract

Lung-resident non-classical monocytes are involved in systemic inflammation in chronic obstructive pulmonary disease

Takuya Saito

Poster

Abstract

Late Breaking Abstract - Extracellular Vesicles as a Delivery System for Gene Editing to Cure Alpha 1 Antitrypsin Deficiency

Tiziana Patrizia Cremona

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}